Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 71 clinical trials
#ChopViolence/#ChopHIV

assessment point) at HBC venues to track trends in violence (i.e., intimate partner, HBC and neighborhood violence), HIV stigma, substance use, mental health, sexual risk and HIV care engagement. In Step 2

  • 0 views
  • 07 Mar, 2021
  • 1 location
Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among HIV-infected infants.

reverse transcriptase inhibitor
ritonavir
antiretroviral therapy
raltegravir
antibody test
  • 210 views
  • 10 Nov, 2021
  • 51 locations
More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents (MOCHA)

The purpose of this study is to determine the dosage for oral and IM Cabotegravir LA and IM Rilpiverine LA and evaluate the safety, acceptability, tolerability, and pharmacokinetics of oral and long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed HIV-infected children and adolescents.

local anesthetic
atazanavir
hiv-1 rna measurement
antiretroviral
body mass index
  • 3 views
  • 01 May, 2022
  • 20 locations
A Study to Determine If a New Shigella Vaccine is Safe Induces Immunity and The Best Dose Among Kenyan Infants

In this study, the tetravalent bioconjugate candidate vaccine Shigella4V will be tested to obtain first-in-human data on its safety and immunogenicity in infants and to identify the preferred dose of Shigella4V in 9 month old infants.

  • 0 views
  • 29 Jan, 2021
  • 2 locations
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

This phase III trial studies how well an antibody (durvalumab) with chemotherapy and radiation therapy (chemoradiation) works in treating patients with stage III non-small cell lung cancer that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, …

tubal ligation
paclitaxel
durvalumab
lung cancer
tumor cells
  • 146 views
  • 16 May, 2022
  • 555 locations
Data Health VET - Data-driven Health Promotion at Vocational Education and Training Schools

The purpose of this study is to investigate the effectiveness of a data driven and dynamic systems approach at Danish Vocational schools to promote student health behavior and wellbeing and school organizational readiness.

Accepts healthy volunteers
  • 0 views
  • 07 Apr, 2022
  • 2 locations
Increasing Cervical Cancer Screening Uptake Among Emergency Department Patients

Invasive cervical cancer is preventable with adequate screening but screening rates are considerably below national goals. Emergency departments care for a disproportionate number of women who are not up to date with recommended cervical cancer screening. This study will evaluate the effectiveness of a mobile technology based behavioral intervention (using …

  • 0 views
  • 14 May, 2021
  • 2 locations
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists …

gliomas
cns neoplasm
cellular therapy
ensartinib
graft-versus-host disease
  • 1029 views
  • 13 May, 2022
  • 103 locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

nivolumab
adenocarcinoma
erlotinib
crizotinib
paclitaxel
  • 1148 views
  • 10 May, 2022
  • 1044 locations
Promoting Reductions in Intersectional StigMa (PRISM) - GHANA

HIV prevalence among men with have sex with men (MSM) in Ghana is at least eight times higher than that of the general population (2%). MSM in Ghana face high levels of stigma due to HIV status (actual or perceived), same-sex behavior, and gender non-conformity. These stigmas are documented barriers …

hiv test
HIV Vaccine
  • 0 views
  • 14 Jun, 2021
  • 1 location